Researchers from the University of Texas Southwestern Medical Center (TX, USA) have identified a biomarker blood test that could identify individuals with early-stage heart disease in need of treatment.
Researchers have analyzed flotillin levels in samples from individuals with and without Alzheimer’s disease (AD) and determined that serum flotillin levels are negatively associated with brain amyloid deposition. Flotillin could serve as a biomarker to estimate brain amyloid deposition, potentially aiding the early diagnosis of AD.
Researchers from the RIKEN Center for Brain Science (Wako, Japan) have identified that hydrogen sulfide production – as a result of MPST gene expression – was higher in postmortem brains from individuals with schizophrenia compared with unaffected individuals.
Scientists from the University of California San Diego (CA, USA) and the University of Alcalá (Madrid, Spain) have reported a pacifier biosensor that could pave the way for future research towards noninvasive saliva biomarker monitoring.
Thermo Fisher Scientific (MA, USA) have announced a new molecular quality control panel. The panel could provide researchers with increased confidence when performing BCR-ABL assays.
Researchers based at the University of Dundee (Scotland) have reported a serum based assay that could be capable of predicting disease severity and clinical outcome of abdominal aortic aneurysm.
Matthew Baker, University of Strathclyde (Glasgow, Scotland), led research for a diagnostic tool that distinguished 87% of blood samples from patients with brain cancer from healthy individuals. This diagnostic tool could improve the speed and accuracy of brain cancer diagnosis.
Researchers from Columbia University School of Engineering and Applied Science (SC, USA) have reported a new novel diagnostic technique that could detect Lyme disease in 15 minutes.
Scientists from the University of Eastern Finland (Finland) and the University of Oulu (Finland) have published a study that demonstratesshows serum neurofilament levels could be used as a biomarker to discriminate frontotemporal dementia from psychiatric disorders.
Standard-flow LC and thermal focusing ESI elucidates altered liver proteins in late stage Niemann–Pick, type C1 disease
Learn more about the use of standard-flow ESI in quantitative proteomic studies and the identification of new NPC1 protein markers in this research article from Bioanalysis.